Christine Ambrosone, PhD

Professor of Oncology
Senior Vice President, Population Sciences
Chair, Cancer Prevention & Control
Roswell Park Cancer Institute

Dr. Ambrosone joined the RPCI faculty in 2002 and is currently the Chair of the Department of Cancer Prevention and Control, and co-leader of the CCSG Population Sciences Program. Dr. Ambrosone graduated from the University at Buffalo summa cum laude, Phi Beta Kappa, and earned her PhD degree at Roswell Park Cancer Institute in 1995. She was a member of the Division of Molecular Epidemiology at the National Center for Toxicological Research in Jefferson, AR until 2000, when she joined the faculty at Mt. Sinai as Director of Epidemiology in the Derald H. Ruttenberg Cancer Center. She is a molecular epidemiologist with background and expertise in the role of gene environment interactions in the etiology of cancer, as well as factors that affect toxicities experienced with cancer treatment, and predictors of cancer survival. Much of her current work focuses on breast cancer disparities.

Dr. Ambrosone was formerly a member of NCI’s EPIC Study Section and the ACS’s study section on Carcinogenesis, Nutrition and the Environment, and has served on several special emphasis panels and SPORE reviews. She is former Senior Editor for Cancer Research, was a member of the Scientific Advisory Board to the Director of the National Cancer Institute until 2012, and serves on Advisory Boards for a number of Cancer Center Programs. Dr. Ambrosone is co-founder and former chair of the Molecular Epidemiology Group of the American Association for Cancer Research, and was Co-Chair of the Southwest Oncology Group’s Committee on Molecular Epidemiology until 2012. Dr. Ambrosone has more than 280 peer-reviewed publications, most related to molecular epidemiology of cancer risk and prognosis.

Research Interests: 
Risk factors for aggressive breast tumor characteristics in African-American women
Using Molecular Epidemiology, with biomarkers of susceptibility and exposure, to elucidate cancer etiology
Examine genetic and modifiable factors that influence cancer treatment outcomes
E-mail Address:
Phone Number: